5217 Winnebago Lane
Austin, TX 78744
United States
512 386 2900
https://www.xbiotech.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 82
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. John Simard | Founder, President, CEO & Chairman | 5,15M | N/A | 1962 |
Ms. Angela Hu | Director of Finance | 183,68k | N/A | 1984 |
Dr. Sushma Shivaswamy Ph.D. | Chief Scientific Officer | 417,16k | N/A | 1978 |
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
XBiotech Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 8. Die grundlegenden Scores sind Audit: 9, Vorstand: 7, Shareholderrechte: 5, Kompensation: 9.